Business

Today, Cofepris will determine whether to approve the use of the Pfizer vaccine in Mexico

This vaccine has already been approved by various health authorities in countries such as Canada, the USA and the UK.

3 min read


Today, Cofepris will determine whether to approve the use of the Pfizer vaccine in Mexico
Today, Cofepris will determine whether to approve the use of the Pfizer vaccine in Mexico

This Friday has the Federal Commission for Protection against Health Risks (Cofepris) decides whether or not to approve the vaccine developed by Pfizer Y. BioNtech. It should be noted that the outlook so far appears positive. According to the Undersecretary of State for Prevention and Health Promotion, Hugo López Gatell:

“The evidence is very encouraging based on the file submitted by Pfizer and BioNtech, which has been reviewed by these powerful health officials. that makes the committee’s work much easier ”.

The Undersecretary of State also noted: “The deliberations of the committee are autonomous. It is very important that they are autonomous. I therefore refrain from comments. Despite the fact that Cofepris is assigned to the Undersecretary of State, it is very important that the autonomy of the administration of the Cofepris Committee. “

It should be recalled that, according to Marcelo Ebrad, Foreign Minister, the application for approval was made at the end of November. And while distribution was expected to begin earlier, if the vaccine is licensed now, it could be distributed next month of January.

It should be added that the vaccine has already been approved by the US Food and Drug Administration (FDA) as well as other regulatory agencies in Canada, Bahrain and the UK.

Image: Agency Anadolu | Getty Images

No Despite the fact that the FDA announced in the past few days that four Pfizer vaccine volunteers had Bell’s palsy, no evidence has yet been found to link this paralysis to the vaccine. However, side effects have been noted in allergy sufferers.

Regarding the latter, Hugo López Gatell stated during a press conference that they should not be a cause for concern, concern or frustration as these are very specific, highly selected cases. And the mechanisms of both drug surveillance and health regulation itself make it possible to protect the population with appropriate recommendations for use. “

For this reason, the Undersecretary of State also pointed out that health authorities such as Cofepris in the case of Mexico are obliged to issue warnings as soon as side reactions are detected, especially with a new product such as the Covid19 vaccination.

Similar Posts